The arrival of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 agonist medication appears to deliver significant improvements in body loss compared to existing therapies. Early research trials have demo